KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Free Cash Flow (2016 - 2026)

AbbVie has reported Free Cash Flow over the past 14 years, most recently at $4.9 billion for Q4 2025.

  • Quarterly Free Cash Flow fell 27.65% to $4.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.8 billion through Dec 2025, changed 0.09% year-over-year, with the annual reading at $17.8 billion for FY2025, 0.09% changed from the prior year.
  • Free Cash Flow was $4.9 billion for Q4 2025 at AbbVie, down from $6.6 billion in the prior quarter.
  • Over five years, Free Cash Flow peaked at $7.7 billion in Q3 2021 and troughed at $1.4 billion in Q1 2025.
  • The 5-year median for Free Cash Flow is $4.9 billion (2021), against an average of $5.2 billion.
  • Year-over-year, Free Cash Flow plummeted 66.94% in 2024 and then surged 140.59% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $4.9 billion in 2021, then surged by 47.61% to $7.2 billion in 2022, then tumbled by 36.96% to $4.5 billion in 2023, then soared by 48.57% to $6.8 billion in 2024, then fell by 27.65% to $4.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Free Cash Flow are $4.9 billion (Q4 2025), $6.6 billion (Q3 2025), and $4.9 billion (Q2 2025).